CHRU de Brest
Brest, 29609, France
NCT Number: NCT02651389
This clinical trials aims to evaluate Tests Performance on a New Digital Orthoptic Platform.
Looking for future studies?
Notify Me7 year and older
All sexes
Observational
Brest, 29609, France
The demography of ophthalmologists is becoming weaker, many tasks are now performed by orthoptists. To optimize the achievement of orthoptic exams and thus make reliable screening in a shorter time, digital tools are developed. They attempt to renew the orthoptic screening equipment that is still made up of numerous tests, often with old designs that must be handled and adapted to each patient which constitutes a significant loss of time.
It therefore appeared necessary for us to develop a platform of digital tools that integrates major tests used for diagnostic purposes, especially a visual acuity test, a stereoscopic vision test, a fusion test and a digital synoptophore enabling a detailed analysis of disorders of binocular vision.
The purpose of the study is to evaluate this new tool, avoiding the mobilization of patients , and quantify whether this platform is precise, reliable, fast, comfortable and allow the realization of a safe examination for the patient and for orthoptics.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: through study completion, an average of 1 hour
University Hospital, Brest
Other
Evaluation de la Performance d'Une Nouvelle Plateforme de Tests de dépistage Orthoptique numériques
Acronym: ESPPADON
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04086524
Amblyopia, Binocular Vision Disorder
Dallas, Texas, United States
View Trial DetailsNCT05070767
Binocular Vision Disorder, Central Nervous System Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT03592615
Binocular Vision Disorder, Cataract
Elkins Park, Pennsylvania, United States
View Trial DetailsNCT07641127
Behavior, Eye Diseases
Cairo, Egypt
View Trial Details